The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations. The list includes Botox and the GLP-1 drug Trulicity. The negotiations stem from ...
Medicare finished negotiating prices for 15 drugs, including Botox and Trulicity. CMS must publish agreed prices by November ...
AbbVie's lawsuit is the latest in a string of Inflation Reduction Act-related legal complaints, but it mounts a unique argument centered on Botox's status as a plasma-derived product. (iStock / Getty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results